首页
Top Medical News
2 days ago
Patients with chronic obstructive pulmonary disease (COPD) may experience short-term changes in retinal and choroidal optical coherence tomography parameters, a recent study has shown.
Jairia Dela Cruz, 4 days ago
For patients with neovascular age-related macular degeneration (nAMD), a less frequent dosing regimen of abicipar appears to improve and stabilize visual acuity over 52 weeks of treatment, and this effect is noninferior to that of monthly ranibizumab injections, as shown in the results of two phase III trials.
Tristan Manalac, 28 Apr ck棋牌
Poor vision may be an indicator of deteriorating cognition in elderly adults, according to a recent Singapore study.
22 Apr ck棋牌
A topical ophthalmic suspension combination of povidone-iodine (PVP-I; 0.6%) and dexamethasone (DEX; 0.1%) appears to confer no clinical benefits to patients with bacterial conjunctivitis, according to the results of a phase III trial.
Tristan Manalac, 21 Apr ck棋牌
In healthy eyes, a thicker macula and ganglion cell-inner plexiform layer (GCIPL) is associated with better visual functioning, according to a recent Singapore study.
Audrey Abella, 20 Apr ck棋牌
Children with anti-TNF* refractory juvenile idiopathic arthritis (JIA)-associated uveitis did not respond well to the interleukin(IL)-6 receptor inhibitor tocilizumab, the phase II APTITUDE trial has shown. However, in the absence of alternatives, tocilizumab might still be a valuable adjunctive therapeutic option for this condition.
Audrey Abella, 16 Apr ck棋牌
The HAWK/HARRIER* trials reveal favourable outcomes with the anti-VEGF**-A brolucizumab – showing noninferiority to fixed-dose aflibercept in improving visual function, a sustained effect, and a favourable safety profile – for the treatment of neovascular age-related macular degeneration (nAMD).